Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Comparison Tests01:13

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognosis Prediction and Shared Decision Making for Personalised Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS project.

Thrombosis and haemostasis·2026
Same author

Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial.

Circulation·2026
Same author

API-CAT Investigators' Decisions on Anticoagulation following Extended Treatment for Cancer VTE.

European heart journal. Cardiovascular pharmacotherapy·2026
Same author

Changes in estimands and prevalence of discrepancies in conclusions under the two-trial paradigm: a systematic review.

Journal of clinical epidemiology·2026
Same author

Impact of adherence to elastic compression stockings on efficacy to prevent postthrombotic syndrome: a prespecified analysis of the Compression Elastique Evaluation du Syndrome post Thrombotique study.

Research and practice in thrombosis and haemostasis·2026
Same author

Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated VTE - Authors' reply.

The Lancet. Haematology·2026

Related Experiment Video

Updated: Jun 24, 2026

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI)
06:26

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI)

Published on: November 27, 2019

[Meta-analyses or megatrials: same level of proof?].

Patrick Mismetti1, Michel Cucherat, Silvy Laporte

  • 1Unité de Pharmacologie Clinique, Service de Médecine Interne et Thérapeutique, EA3065, CIE3, Centre Hospitalier Universitaire, Saint-Etienne. patrick.mismetti@chu-st-etienne.fr

Presse Medicale (Paris, France : 1983)
|February 6, 2007
PubMed
Summary

Meta-analyses require rigorous methodology, including all study results and strict inclusion criteria, to avoid bias. Careful analysis of heterogeneity and potential biases is crucial for reliable treatment effect estimation.

More Related Videos

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Experiment Videos

Last Updated: Jun 24, 2026

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI)
06:26

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI)

Published on: November 27, 2019

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Area of Science:

  • Biostatistics
  • Clinical Epidemiology
  • Evidence-Based Medicine

Background:

  • Meta-analyses synthesize findings from multiple studies.
  • Discrepancies between meta-analyses and megatrials can arise from methodological biases.
  • Ensuring methodological rigor is essential for accurate meta-analytic results.

Purpose of the Study:

  • To highlight the critical role of methodology in meta-analysis.
  • To outline best practices for conducting robust meta-analyses.
  • To discuss methods for assessing and mitigating bias in meta-analyses.

Main Methods:

  • Emphasizing exhaustive literature reviews including negative results.
  • Stressing the importance of a priori defined inclusion/exclusion criteria for study selection.
  • Detailing analytical techniques for bias detection (e.g., funnel plots) and heterogeneity assessment (e.g., meta-regression).

Main Results:

  • Meta-analysis quality is contingent on the methodological rigor of included studies.
  • Heterogeneity in protocols, dosing, and outcomes can bias treatment effect estimation.
  • Individual patient data meta-analyses allow for subgroup analysis and personalized treatment assessment.

Conclusions:

  • Meta-analyses offer valuable insights into treatment strategies across diverse populations.
  • Prospective meta-analyses can enhance data consistency and reduce heterogeneity.
  • Adherence to strict methodological standards is paramount for the validity and reliability of meta-analysis findings.